Kurt F. Hauser, Ph.D.

Pharmacology & Toxicology Virginia Commonwealth University School of Medicine, Richmond, VA 
Neuropharmacology, NeuroAIDS, Substance abuse, Glia
"Kurt F Hauser"
Mean distance: 17.79 (cluster 32)
Cross-listing: Chemistry Tree


Sign in to add trainee
Anne Stiene-Martin grad student 1988-1992 University Kentucky
John G. Osborne grad student 1989-1992 University of Kentucky College of Medicine
Julie A. Gurwell grad student 1990-1993 University of Kentucky College of Medicine
Valeriya Khurdayan grad student 2003-2005 University of Kentucky College of Medicine
Kristen A. Kelps grad student 2006-2007 University of Kentucky College of Medicine
Elizabeth E. Podhaizer grad student 2008-2014 VCU
Mary E. Sorrell grad student 2009-2014 VCU
William D. Marks grad student 2012-2017 VCU School of Medicine
Jason J. Paris post-doc 2014- VCU School of Medicine
Arianna Lark post-doc 2017- VCU
Sara R. Nass post-doc 2017- VCU
Lisa A. Opanashuk post-doc 1997-1999 University of Kentucky College of Medicine
Robin J. Goody post-doc 2000-2002 University of Kentucky College of Medicine
Shreya K. Buch post-doc 2003-2006 University of Kentucky College of Medicine
Nazira El-Hage post-doc 2003-2007 University of Kentucky School of Medicine
Masami Suzuki post-doc 2008-2009 VCU School of Medicine
Sylvia Fitting post-doc 2008-2014 VCU School of Medicine
Seth M. Dever post-doc 2010-2014 VCU School of Medicine
Dong Chen post-doc 2013-2015 VCU School of Medicine
Christina J. Schier post-doc 2013-2016 VCU School of Medicine
Jason J. Paris post-doc 2014-2016 VCU School of Medicine
Michael Ohene-Nyako post-doc 2019-2022 VCU School of Medicine
Indrapal N. Singh research scientist 2002-2006 University of Kentucky College of Medicine
Nazira El-Hage research scientist 2007-2014 VCU School of Medicine
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hauser KF, Ohene-Nyako M, Knapp PE. (2022) Accelerated brain aging with opioid misuse and HIV: New insights on the role of glially derived pro-inflammation mediators and neuronal chloride homeostasis. Current Opinion in Neurobiology. 78: 102653
Toma W, Paris JJ, Warncke UO, et al. (2022) Persistent sensory changes and sex differences in transgenic mice conditionally expressing HIV-1 Tat regulatory protein. Experimental Neurology. 358: 114226
Leibrand CR, Paris JJ, Jones AM, et al. (2022) Independent actions by HIV-1 Tat and morphine to increase recruitment of monocyte-derived macrophages into the brain in a region-specific manner. Neuroscience Letters. 136852
Lark ARS, Silva LK, Nass SR, et al. (2022) Progressive Degeneration and Adaptive Excitability in Dopamine D1 and D2 Receptor-Expressing Striatal Neurons Exposed to HIV-1 Tat and Morphine. Cellular and Molecular Neurobiology
Nass SR, Ohene-Nyako M, Hahn YK, et al. (2022) Neurodegeneration Within the Amygdala Is Differentially Induced by Opioid and HIV-1 Tat Exposure. Frontiers in Neuroscience. 16: 804774
McLane VD, Lark ARS, Nass SR, et al. (2022) HIV-1 Tat reduces apical dendritic spine density throughout the trisynaptic pathway in the hippocampus of male transgenic mice. Neuroscience Letters. 782: 136688
Yarotskyy V, Lark ARS, Nass SR, et al. (2022) Chloride channels with CLC-1-like properties differentially regulate the excitability of dopamine receptor D1- and D2-expressing striatal medium spiny neurons. American Journal of Physiology. Cell Physiology
Barbour AJ, Nass SR, Hahn YK, et al. (2021) Restoration of KCC2 Membrane Localization in Striatal Dopamine D2 Receptor-Expressing Medium Spiny Neurons Rescues Locomotor Deficits in HIV Tat-Transgenic Mice. Asn Neuro. 13: 17590914211022089
Nass SR, Lark ARS, Hahn YK, et al. (2021) HIV-1 Tat and morphine decrease murine inter-male social interactions and associated oxytocin levels in the prefrontal cortex, amygdala, and hypothalamic paraventricular nucleus. Hormones and Behavior. 133: 105008
Huang B, Wang H, Zheng Y, et al. (2021) Structure-Based Design and Development of Chemical Probes Targeting Putative MOR-CCR5 Heterodimers to Inhibit Opioid Exacerbated HIV-1 Infectivity. Journal of Medicinal Chemistry
See more...